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The use of adult skeletal muscle stem cells (MuSCs) for cell therapy has been attempted for decades, but still encounters considerable dif-
ficulties. MuSCs derived from human induced pluripotent stem cells (hiPSCs) are promising candidates for stem cell therapy to treat
Duchenne muscular dystrophy (DMD). Here we report that four transcription factors, HEYL, KLF4, MYOD, and PAX3, selected by
comprehensive screening of different MuSC populations, enhance the derivation of PAX3-positive myogenic progenitors from fibro-
blasts and hiPSCs, using medium that promotes the formation of presomitic mesoderm. These induced PAX3-positive cells contribute
efficiently to the repair of DMD-damaged myofibers and also reconstitute the MuSC population. These studies demonstrate how a com-
bination of core transcription factors can fine-tune the derivation ofMuSCs capable of contributing to the repair of adult skeletal muscle.
INTRODUCTION
The muscular dystrophies are a group of inherited skeletal
muscle disorders characterized clinically by progressive
muscle weakness and wasting. Duchenne muscular dystro-
phy (DMD) is among the most common and severe forms
of these muscle diseases. DMD is caused by mutations or
deletions in the Dmd gene, which lead to loss of muscle fi-
ber integrity and continuous muscle damage. This damage
leads to the rapidwasting of skeletalmuscles, and there is as
yet no cure, although a number of promising approaches
are being developed to retard the progression of DMD
symptoms (Guiraud et al., 2015). Cell replacement therapy
uses extrinsic myogenic cells that express functional dys-
trophin protein to replace the abnormal skeletal muscle tis-
sue of individuals with DMD (Negroni et al., 2016).
Skeletal muscle tissue has its own intrinsic repair and
maintenance system, which depends on adult muscle
stem cells (MuSCs). MuSCs are closely associated with the
muscle fiber, hence their description as satellite cells, and
are normally quiescent, but begin to proliferate in response
to muscle injury or during intense exercise. They enter the
myogenic differentiation program, fuse with damaged my-
ofibers or form de novo fibers, and also reconstitute the
quiescent MuSC population (Collins et al., 2005). Mouse
MuSCs that have no Dmd mutation, when engrafted into
the damagedmuscle of DMDmice, contribute to the regen-
eration of DMD myofibers, which are now positive for
functional dystrophin protein (Cerletti et al., 2008).
Skeletal muscle regeneration is regulated by families of
transcription factors also essential for skeletal muscle for-
mation in the embryo. PAX3, a paired box transcription
factor, is expressed in the paraxial mesoderm of newly
forming somites and then in the dorsal compartment of
somites, the dermomyotome, which will give rise to
myogenic progenitor cells. Pax3, and its sister gene, Pax7,
also expressed later in all muscle progenitor cells, lie up-
stream of the MYOD family of basic-helix-loop-helix tran-
scription factors that play an essential role inmuscle forma-
tion. The MYOD family is specific to skeletal muscle,
whereas PAX3 and PAX7 are also expressed in some cells
of the central nervous system, and PAX3 plays an impor-
tant role in the development of neural crest cells (Bucking-
ham and Relaix, 2015). In the skeletal muscle context, the
population of PAX3/PAX7-positive progenitors is essential
for myogenic growth during development and is also re-
garded as the source of adult MuSCs (Gros et al., 2005).
Recent studies have revealed that core transcription factors,
expressed in adult stem cells of a number of different tis-
sues, can induce and maintain a specific cell lineage
directly when introduced into pluripotent stem cells
(PSCs) and into other cell types (Morris, 2016). A classic
example of such tissue-specific conversion is provided by
the MYOD family, which when expressed in non-muscle
cells activates the endogenousMyoD family genes and leads
to the establishment of the gene regulatory network
required for the subsequent formation of skeletal muscle
(Weintraub et al., 1989).
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In the study reportedhere,weestablished adefined system
to inducemyogenic stemcells fromfibroblasts, identified by
expression of a Pax3-GFP reporter. This is based on a combi-
nation of transcription factors which, together with appro-
priate mesodermal culture medium, are more effective
thananysingle factor ingeneratingPAX3-positivemyogenic
progenitors that when engrafted into dystrophic mouse
muscle efficiently regenerate dystrophin-positive fibers and
reconstitute the PAX7-positive stem cell compartment.
These results provide new insight into the core transcription
factors that underlie the conversion of non-muscle cells to
myogenic progenitors of potential therapeutic interest.
RESULTS
MYOD Induces Myogenic Cell Conversion, but Not
PAX3-Positive Muscle Stem Cells
We have developed Pax3GFP/+;MyoD-Cre;
Rosa26CAG-LSL-tdTomato/+ (Pax3-GFP;MyoD-tdTomato) com-
pound mice to visualize GFP-positive MuSCs (green in
Figure 1A) and MYOD-primed myogenic cells (red in
Figure 1A). Mouse embryonic fibroblasts isolated from
this mouse line (Figures S1 and S2A) were transfected
with a Pax3- and/or MyoD-expression pMX vector. MyoD-
or Pax3+MyoD-infected cells are gradually converted into
myogenic cells, which express the endogenous MyoD
gene, shown as tdTomato-positive cells (Figure 1B), but
not Pax3-GFP-positive cells corresponding to myogenic
progenitor/muscle stem cells (right panels in Figure 1B).
We could detect MyoD-primed, tdTomato-positive cells
from day 3 after MyoD transfection, and the proportion
of these tdTomato-positive cells increased for 2 weeks after
the transfection, whereas Pax3-GFP-positive cells were
rarely detected (Figure 1C). Expression of Pax3 and MyoD
was not enough to induce PAX3-positive cells from
fibroblasts.
Transcription Factors that Induce Pax3-Positive
Myogenic Cells
Next, we investigated the expression of potential regula-
tory genes in Pax3-GFP-positive cells isolated from skeletal
muscle of fetal, postnatal, and adult mice (Figure S1A). We
used these three sources of cells to identify genes that are
common to the MuSC identity, irrespective of other fea-
tures of the cells at different developmental stages. Genes
encoding transcription factors that are highly expressed in
all three conditions, compared with other cell types, were
selected (Figures S1B and S1C; Tables S1 and S2). We
first investigated whether expression of a combination
of these transcription factors could induce Pax3-GFP-posi-
tive cells derived from mouse embryonic fibroblasts of
Pax3-GFP;MyoD-tdTomato embryos. Pax3-GFP-expressing
cells were generated most efficiently by a mixture of eight
transcription factors (+8F), Egr2, Heyl, Klf4, Mef2c, MyoD,
Pax3, Pax7, and Pitx2, which were highly expressed in all
three PAX3-positive muscle progenitor/stem cell popula-
tions (Figures 2A, 2B, and S3B). We attempted to deter-
mine which of the eight transcription factors were essen-
tial for the induction of PAX3-positive MuSCs. Pax3,
Heyl, Klf4, and MyoD had the ability to induce Pax3-GFP
cells effectively (Figure S2C). However, MYOD protein
could not be detected in adult quiescent MuSCs as previ-
ously reported (Montarras et al., 2005). We therefore
controlled the expression level of MYODwith doxycycline
(DOX). Pax3, Heyl, Klf4 (3F), and constant MYOD
(++DOX) could also induce Pax3-GFP as seen for 8F; how-
ever, 3F and transient MYOD expression for 72 h (+DOX)
effectively enhanced the population of GFP-expressing
cells (Figure 2C). These induced GFP-positive cells, selected
by fluorescence-activated cell sorting (FACS), were de-
tected as Pax7-positive cells (Figure 2D). These GFP-posi-
tive cells also expressed endogenous Pax7, Calcitonin recep-
tor, Sprouty1, and Syndecan4 transcripts, markers of muscle
satellite cells (Fukada et al., 2007; Shea et al., 2010), and
did not show elevated levels of transcripts for Sox1 or
Sox10, markers of neural or neural crest cells (Figure 2E).
To compare induced GFP-positive cells with endogenous
Pax3-GFP MuSCs, we expanded both populations on
cell-culture dishes for 4 days. The numbers of growing cells
were similar, although induced GFP-positive cells had a
tendency to form aggregates (lower panel in Figure 2F)
and less tendency to spontaneously form muscle fibers
(Figure 2F), with maintenance of mononucleated progen-
itors reflected by a higher level of Pax7 transcripts (Fig-
ure 2G). Both GFP-positive cell populations underwent
myogenic differentiation when cultured under low serum
conditions, as shown by staining for skeletal muscle
myosin heavy chain (MyHC, Figure 2H). Differentiated
MyHC-positive muscle cells from induced GFP cells were
elongated and formed fewer, thinner fibers (Figure 2I). In
these cultures, compared with differentiated muscle satel-
lite cells, transcripts of Pax7 were higher indicating more
maintenance of muscle progenitors, with similar levels
of transcripts for embryonic MyHC (Myh3) and lower
levels of transcripts of Myh7 and Myh1 encoding slow
and fast adult MyHCs, respectively (Figure 2J). These re-
sults suggest that the induced GFP cells have a less mature
skeletal muscle phenotype under these culture conditions.
In conclusion, the four factors (4F) have the competence
to convert mouse embryonic fibroblasts to PAX3- and
PAX7-positive cells that have myogenic differentiation po-
tential as indicated by the activation of genes for skeletal
muscle-specific proteins such as Myogenin (Myog) and skel-
etal muscle MyHC. This was also the case for human
dermal fibroblasts (Figure S3).
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Mesodermal Differentiation with PAX3GFP/+ Human
Induced PSCs
To identify PAX3-positive human MuSCs, we generated
Pax3GFP/+ knockin human induced PSCs (hiPSCs) using a
BAC construct with a GFP insertion in the ATG start codon
of the human PAX3 gene (Figure S4A). Intrinsic GFP expres-
sion in cells derived from these hiPSCs could be detected in
teratomas or neural precursors after SFEBq induction (GFP
expressions in Figure 3A; Watanabe et al., 2005). After cell
sorting with induced cells, GFP-positive cells were success-
fully immunostained with an anti-PAX3 antibody, while
GFP-negative cells did not show the transcription of
PAX3 (Figure 3B). This hiPSC PAX3GFP/+ knockin cell line
was further genetically modified by the introduction of a
DOX-inducible MYOD cassette using the piggyBac trans-
poson system (Tanaka et al., 2013). To induce differentiated
myogenic cells derived from these hiPSCs, we administered
DOX continuously for at least a week (Figure S4B). This
resulted in myogenic cell differentiation but GFP-
positive cells were only rarely detected, in keeping with
the result seen with mouse fibroblasts (Figure 1C
and +3F++DOX in Figure 2C). However, transiently DOX-
treated hiPSCs gave rise to significantly more GFP-positive
cells than continuous or no DOX administration (DOX for
72 h in Figure 3C). To investigate gene expression in these
GFP-positive cells we analyzed myogenic, neural, and neu-
ral crest markers, since Pax3 is expressed in the correspond-














































Figure 1. MYOD and PAX3 Are Not Sufficient to Induce Myogenic Stem Cells, but Result in Differentiated Cells
(A) Schematic representation of skeletal muscle development in mouse embryogenesis. Pax3GFP/+ (Pax3-GFP) indicates dermomyotome
(DM; green), and MyoD-Cre;Rosa26CAG-LSL-tdTomato/+ (MyoD-tdTomato) primed populations were initially labeled in myotome (M; Red). NT,
neural tube; DRG, dorsal root ganglia; N, notochord; DML, dorsomedial lip; VLL, ventrolateral lip.
(B) Mouse Pax3, MyoD, and Pax3+MyoD infected mouse embryonic fibroblasts (MEFs) derived from Pax3-GFP;MyoD-tdTomato embryos after
7 days. Scale bars, 50 mm.
(C) FACS analyses with MEFs following the time course after MyoD infection, from day 3 to day 14.





Figure 2. The Combination of Four Transcription Factors Induces PAX3-Expressing Myogenic Cells from Mouse Fibroblasts
(A and B) Detectable GFP expression in MEFs (arrowheads) infected with eight transcription factors (+8F) after 14 days.
(C) FACS analyses of GFP-expressing cells with mouse Pax3, HeyL, and Klf4 (+3F) and persistent MYOD (++DOX) or transient MYOD for 72 h
(+DOX).
(D) Immunofluorescence for GFP (labeled with Alexa 488, green) and Pax7 (labeled with Alexa 647, red) with GFP-positive cells induced by
3F and transient MYOD acceleration (+3F+DOX).
(E) Expression levels of Pax7, Calcr, Spry1, Sdc4, Sox1, and Sox10 transcripts levels in induced Pax3-GFP-positive (gray) or -negative
(white) cells with 3F+DOX. n = 3 independent replicates; p values are determined by t test from a two-tailed distribution. **p < 0.01,
*p < 0.05.
(F) Morphological features of cultured GFP-positive satellite cells (GFP+ MuSCs; upper panel) and three transcription factors with transient
DOX treatment (+3F+DOX GFP+ cells; lower panel) for 4 days.
(G) Myogenic transcripts of Pax7, endogenous MyoD (MyoD UTR), and Myog relative to Rpl13a transcripts in GFP+ cells cultured for 4 days.
n = 3 independent replicates; p values are determined by t test from a two-tailed distribution. *p < 0.05.
(H) Differentiated myogenic cells (DAPI, blue; MyHC, Alexa 647, red) from induced GFP-positive cells with 3F+DOX (right panels) compared
with mouse Pax3-GFP satellite cells (GFP+ MuSCs; left panels) on 2% horse serum for 7 days.
(I) Quantification of the ratio of DAPI-positive mono (N = 1) or multiple nuclei (N = 2, 3 or N > 3) present in single MyHC-positive myofibers
of (H). n = 3 independent replicates; p values are determined by t test from a two-tailed distribution. *p < 0.05.
(J) Transcriptional levels of myogenic markers Pax7, MyoD, Myog, Myh3, Myh7, and Myh1, differentiated for 7 days from GFP+ cells. n = 3
independent replicates; p values are determined by t test from a two-tailed distribution. *p < 0.05.
Error bars indicate ±SEM. Scale bars, 50 mm.






Figure 3. Mesodermal Differentiation from PAX3GFP/+-Derived hiPSCs
(A) GFP expression in induced teratoma (left panels) and neural precursors by SFEBq induction (right panels) derived from PAX3GFP/+
hiPSCs. Scale bars, 200 mm.
(B) Immunostaining with Pax3 antibody in GFP-sorted cells (upper panel) and the ratio of PAX3 transcript relative to RPL13A in GFP-sorted
cells (lower panel). Red, PAX3; blue, DAPI. Scale bar, 100 mm.
(C) FACS profiles of Pax3GFP/+; Tet-On MYOD hiPSCs with or without continuous doxycycline (DOX) treatment (left panel, no DOX; middle
panel, continuous DOX) and transient treatment for 72 h and cultured for a total of 7 days (right panel, DOX for 72 h).
(D) Relative transcription levels of dermomyotome (DMRT2), myogenic (MYF5), and neural (SOX1, SOX10) progenitors in induced GFP-
positive cells treated with doxycycline for 72 h and cultured for a total of 7 days. n = 3 independent replicates; p values are determined by
t test from a two-tailed distribution. *p < 0.05.
(E) Schematic representation of the induction to mesodermal cells from hiPSCs.
(F) Morphological features and GFP expression of mesodermal differentiated cells derived from PAX3GFP/+;Tet-On MYOD hiPSCs.
(legend continued on next page)
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derived from DOX-treated hiPSCs acquired myogenic po-
tential, as shown by the presence of MYF5 transcripts;
however, neural transcripts of SOX1 or SOX10were also de-
tected (Figure 3D). This suggests that neural PAX3-positive
cells may also arise even in the MuSC culture condition
with transient MYOD expression (Figure S4C). We there-
fore attempted to exclude neural induction from hiPSCs
by using modified cell-culture conditions to favor meso-
dermal, not ectodermal, lineages. Several groups have re-
ported culture conditions that promote induction of so-
mitic cells in the mesodermal lineage from human PSCs,
and we adopted a method to induce paraxial mesodermal
cells by manipulation of transforming growth factor b,
bone morphogenetic protein, and Wnt signaling (Naka-
jima et al., 2018, Figure 3E). PAX3-GFP-expressing cells
were obtained in induced aggregates of cells, reminiscent
of mouse somites (Figure 3F), showing partial expression
of DLL1, which marks the paraxial mesodermal lineage,
during somite differentiation (green in Figure 3G).We eval-
uated inducedDLL1+ or DLL1+PAX3+ cells for expression of
transcripts for MESOGENIN (MSGN), TBX6, and PDGFRa,
which are presomitic mesodermal markers, or DMRT2,
which is a dermomyotome marker of early somites (Sato
et al., 2010). Successful mesodermal induction was demon-
strated by high levels of MSGN, TBX6, or PDGFRa tran-
scripts in total DLL1+ cells, and high DMRT2 expression
in DLL1+GFP+ double-positive cells (Figure 3H). We next
analyzed neural or non-neural transcripts in PAX3-GFP
cells under different differentiation conditions. As shown
in Figure 3I, on treatment with 5 mM CHIR99021, which
promotes neural crest lineages derived from hiPSCs,
including hiPSCs transiently treated with DOX for 72 h,
the level of SOX1 or SOX10 transcripts was highly upregu-
lated; however, GFP-positive cells treated with the meso-
dermal induction procedure for 1week did not express neu-
ral crestmarkers but did express transcripts forDMRT2, also
seen for a longer period of 2 weeks in culture (Figure 3I).
Additional Expression of Four Transcription Factors in
Mesodermal Cells Induces PAX3-Positive Muscle Stem
Cells
Using induced mesodermal cells labeled with DLL1,
derived from hiPSCs, we attempted to determine which
of the eight transcription factors was essential for the in-
duction of PAX3-positive MuSCs (Figures 4A and S2). The
combination of PAX3, HEYL, KLF4, and inducible transient
MYOD (+3F+DOX) had the ability to induce PAX3-GFP
(mCherry-positive/negative) cells effectively, in contrast
to single transient or continuous MYOD (+DOX
or +3F++DOX; Figures 4B and 4C). To evaluate whether
these induced GFP cells have the characteristics of MuSCs,
we checked cell-surface antigens, transcripts in these cells,
and myogenic differentiation activity. Both CD56 and
CD82, markers of myogenic stem cells andmyocytes (Alex-
ander et al., 2016), were co-expressed on 60% of 4F-
induced Pax3-GFP cells (Figure 4D). These GFP-sorted cells
showed mainly PAX7-positive staining; however, PAX7-
negative cells were detected as MYOG-positive differenti-
ated muscle cells (Figure 4E). When GFP-positive or -nega-
tive populations of CD56-positive myogenic cells were
seeded under myogenic differentiation conditions with
2% horse serum, GFP-positive cells labeled the differentia-
tionmarker MYOG orMYHC, although only a fewmyofib-
ers were observed (Figures 4F–4H) in comparison with GFP-
negative cells of the CD56+ population. This is consistent
with downregulation of PAX3, and subsequently the GFP
reporter on muscle differentiation and muscle fiber forma-
tion; the continuing presence of exogenous PAX3 tran-
scripts in this population of myogenic cells may explain
why the number of myofibers is low (Figure 4I; Relaix
et al., 2006). Comparison of transcript levels of DMRT2,
NFIX that marks myogenic progenitors at fetal stages (Mes-
sina et al., 2010), or NAP1L5 that marks adult MuSCs (Pal-
lafacchina et al., 2010) shows that +3F+DOX leads to
myogenic progenitor/stem cells of fetal and adult types
(Figure 4J). Furthermore, the levels of PAX7 or CALCR tran-
scripts specifically expressed in adult quiescent MuSCs
were high in induced GFP cells derived from mesodermal
lineages compared with DOX-induced GFP cells (Fig-
ure 4K). In the absence of exogenous PAX3, the three fac-
tors HEYL, KLF4, and MYOD also induced PAX3-GFP cells
from mesodermal cells; however PAX7, CALCR, or
NAP1L5 transcripts in GFP+ cells were all decreased (Fig-
ure 5A), and the cells showed less myogenic differentiation
(Figures 5B–5D). Comparison of the results obtained with
induction by the four factors identified here with previ-
ously published protocols for inducing MuSCs, using
growth factors (Chal et al., 2015) or with induced PAX7
(Darabi et al., 2012), showed that the protocol we describe
leads to more mature MuSCs expressing adult satellite cell
(G) Cultured cell populations on mesodermal induction for 7 days (left panel) and subpopulation of ectodermal GFP (GFP+DLL1) and
mesodermal GFP (green box, GFP+DLL+) derived from presomitic mesoderm (GFPDLL1+) labeled with the hDLL1 antibody (right panel).
(H) Transcription analyses of each type of sorted cells with presomitic mesodermal markers (MSGN, TBX6, PCGFRa) and the dermomyotome
marker DMRT2. n = 3 independent replicates; p values are determined by Dunnett’s multiple-comparisons test. *p < 0.05, **p < 0.01.
(I) Transcription analyses with PAX3-GFP-sorted cells on each differentiated condition. n = 3 independent replicates; p values are
determined by Dunnett’s multiple-comparisons test. *p < 0.05, **p < 0.01.
Error bars indicate ±SEM.
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markers (Figure S5). We conclude that cells from meso-
dermal cells with the four transcription factors have the
characteristics of skeletal MuSCs and show myogenic po-
tential when cultured in vitro.
Transplanted PAX3-GFP Cells in the DMD Mouse
Model Contribute to Skeletal Muscle Regeneration
Quiescent adult MuSCs are highly potent for skeletal mus-
cle regeneration and form muscle fibers when they are
transplanted into damaged muscle. We have previously re-
ported that embryonic muscle precursors that are Pax3-
GFP positive do not contribute effectively to regenerating
muscle fibers in Dmd/y mice (Sakai et al., 2013). We now
tested the in vivo myogenic capacity of Pax3-GFP-positive
cells obtained from hiPSCs by the three factors and tran-
sient MYOD procedure.Dmd/y;NSG (DMD) mice were en-
grafted with GFP+ cells, which were directly collected after
sorting to evaluate their MuSC regenerative capacity (Fig-
ure 6A). These GFP-positive cells effectively contributed
to regenerated muscle fibers after their engraftment into
DMD mice, as detected by human Dystrophin (DYS)
expression in regenerating muscle fibers (mean = 282
DYS+ fibers/section of the tibialis anterior (TA) muscle,
9.4% positives in total myofibers of the TA muscle, red in
Figures 6B and 6C). When cultured for 4 days ex vivo,
GFP-negative cells induced by the four factors (+cultured
GFP+ or +GFP, +3F+DOX), or GFP-positive cells induced
by the four factors (GFP, +3F+DOX) or after DOX alone
(+GFP+, +DOX), these cells showed significantly reduced
regenerative efficiency when the same number of cells
was injected (0.43%, 0.60%, or 0.31%, respectively, Fig-
ure 6C). To investigate the capacity of PAX3-GFP-positive
cells to renew the satellite cell compartment, we analyzed
numbers of human-derived PAX7+ cells underneath the
basal lamina of mouse skeletal muscle fibers (arrowheads
in Figure 6D). GFP-positive cells obtained after treatment
with four factors occupied a satellite cell position on regen-
erated fibers, thus indicating renewal of the satellite cell
compartment (mean = 27 PAX7+hLMNA+ cells/section, Fig-
ures 6D and 6E). In contrast, GFP-negative cells or other
induced GFP cells, including MYOD-expressing cells
induced by DOX alone, did not contribute to reconstitu-
tion of the satellite cell compartment (Figure 6E). Trans-
planted cells, which were induced by four factors, were de-
tected in the position of muscle satellite cells and also in
the interstitial area. Whereas cells in the satellite position
did not show MYOD-positive signals (green arrowheads
in left panel of Figure 6F), those in the interstitium were
MYOD positive, consistent with their status as activated
myogenic cells that are still contributing to regeneration
(green arrowheads in right panel of Figure 6F). To under-
stand the relationship between regeneration and cell
expansion of transplanted cells, we found Ki67-positive
cells in the transplanted area and non-proliferating trans-
planted cells on regenerated muscle fibers, which were
DYS positive (red arrowheads in Figure 6G). Ki67-positive
Figure 4. Selected Four Transcription Factors Induce Human PAX3-Positive Muscle Stem Cells Derived from the Mesodermal
Lineage
(A) Procedure for the induction of PAX3-GFP cells derived from mesodermal lineage.
(B) GFP or mCherry expression in transient MYOD-induced populations after expression of PAX3, HEYL, and KLF4 transcription factors
(+3F), and doxycycline for 72 h (+DOX).
(C) The contrasting proportion of induced PAX3-GFP cells with transient single doxycycline treatment (+DOX) and three transcription
factors and transient/continuous doxycycline (+3F+DOX/+3F++DOX).
(D) The FACS profile of CD56 and CD82 expression, human myogenic cell-surface markers, in induced cells. More than 60% of PAX3-GFP cells
were merged with CD56+CD82+ as double positives.
(E) Immunostaining with anti-PAX7 (left panel, labeled with Alexa 488, light blue) and anti-MYOGENIN (MYOG; right panel, labeled with
Alexa 647, purple) antibodies in CD56+CD82+GFP+ sorted cells. GFP signals were not detected after immunostaining.
(F and G) In vitro myogenic differentiation assay with induced PAX3-GFP-positive (CD56+GFP+) or -negative (CD56+GFP) cells of CD56-
positive cells in 2% of horse serum medium for 7 days. MYOG, purple; MYHC, light blue (labeled with Alexa 647); DAPI, blue.
(H) Percentage of differentiated myogenic cells presented as the ratio of MYOG or MYHC/DAPI fluorescence. n = 3 independent replicates; p
values are determined by t test from a two-tailed distribution. *p < 0.01.
(I) Ratio of transcripts of PAX3 relative to RPL13A in myogenic differentiated cells from PAX3-GFP-positive (+) or -negative cells () of the
CD56+ population. n = 3 independent replicates; p values are determined by t test from a two-tailed distribution. *p < 0.01.
(J) Fetal (NFIX) and adult (NAP1L5) transcriptional analyses with PAX3-GFP-positive or -negative cells of CD56-positive cells induced by
transient DOX treatment plus three transcription factors (+3F+DOX). Mesodermal GFP-expressing cells, marked by DMRT2 (dermomyotome),
were used as control (GFP+ mesoderm). n = 3 independent replicates; p values are determined by Dunnett’s multiple-comparisons test. *p <
0.01.
(K) Transcriptional analyses with GFP-positive cells induced by transient DOX treatment plus three transcription factors (+3F+DOX). GFP-
expressing cells with or without DOX were used as control (GFP+ DOX/+DOX). n = 3 independent replicates; p values are determined by
Dunnett’s multiple-comparisons test. *p < 0.01.
Error bars indicate ±SEM. Scale bars, 50 mm.
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cells were detected in the interstitial area, not in the DYS-
expressing area (white arrowhead in Figure 6G). We
conclude that induced-PAX3 positive cells, grown under
mesodermal culture conditions and expressing the four
transcription factors, contribute to the formation of new
skeletal muscle fibers, thus recapitulating aspects of normal
regeneration after cell transplantation in vivo.
DISCUSSION
Herewe define a combination ofmyogenic reprogramming
factors that can induce MuSCs, capable of regenerating
adult skeletal muscle. This is in contrast to MYOD, which
converts non-muscle cells to the myogenic lineage, with
the formation of differentiating myoblasts. However, these
cells, which do not express PAX3 or PAX7, do not have the
regenerative potential of adult MuSCs, as illustrated by our
analysis of engraftment with mesodermal cells expressing
MYOD alone or the effect of culturing MuSCs, which leads
to the activation of MYOD expression with downregula-
tion of PAX3 or PAX7 and subsequent loss of their capacity
to repair injuredmuscle after engraftment (Montarras et al.,
2005). Genetic tracing experiments have shown that most
MuSCs are derived from cells that had expressed myogenic
regulatory factors, MYOD, MYF5, or MRF4, and indeed still
transcribe the Myf5 gene; however the corresponding pro-
teins are undetectable in adult MuSCs (Crist et al., 2012;
Sato et al., 2014).
To test the effects of controlled MYOD activation on the
induction of MuSCs, we used the Tet-On MYOD system.
MYOD activation for over a week efficiently leads to
A B
DC
Figure 5. The Effect of Removing PAX3 from the Candidate Four Transcription Factors for Inducing PAX3-Expressing Muscle Stem
Cells from hiPSCs
(A) FACS profile for detecting PAX3-GFP cells with or without PAX3 from mesodermal cells.
(B) Transcriptional analyses with GFP-positive cells induced by transient DOX treatment plus three transcription factors (+3F+DOX) or two
transcription factors (no PAX3, +2F+DOX). n = 3 independent replicates; p values are determined by t test from a two-tailed distribution.
*p < 0.01.
(C) Myogenic differentiation with induced PAX3-GFP-positive cells in 2% of horse serum medium for 7 days. MYOG, purple (labeled with
Alexa 647); DAPI, blue.
(D) Percentage of differentiated myogenic cells presented as MYOG/DAPI ratio. n = 3 independent replicates; p values are determined by
t test from a two-tailed distribution. *p < 0.01.
Error bars indicate ±SEM.
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terminally differentiated skeletal muscle cells derived from
hiPSCs (Figure S4B); however, transient induction of
MYOD expression led to the presence of PAX3-expressing
cells and the absence of differentiated cells marked by skel-
etal muscle MyHC. In these cultured cells, we detected not
only myogenic but also neural cells in the presence of
persistent MYOD activation under conditions of high fetal
bovine serum (FBS), suitable for ex vivo expansion of
myogenic cells (Figure S4C). Transient MYOD activation
and exogenous factors in the serum appear not to prevent
some non-skeletal muscle derivatives from iPSCs, although
MYODmight be essential for the induction of MuSCs from
mouse fibroblasts as previously reported (Bar-Nur et al.,
2018). Non-myogenic neural derivatives were excluded in
these experiments when hiPSCs were cultured under me-
dium conditions that favormesoderm. In these conditions,
early somite markers were observed. In the experiments
described here, we employed the same hiPSC line to
generate two subclones, which have different copy
numbers ofMYOD transgenes after treatment with the pig-
gyBac transposon system, and these were used for the in-






Figure 6. Induced Human PAX3-GFP Cells
Have High Regenerative Capacity in Dys-
trophin-Deficient Mice
(A) Flowchart for the transplantation into
DMD/y;NSG mice with PAX3-GFP-positive
cells derived from human iPSCs.
(B) Comparison between the same number
of GFP-positive and -negative cells (+GFP+
cells, +GFP cells) for transplantation. Immu-
nostaining for dystrophin (DYS; labeled with
Alexa 594, red), human nuclear lamin A/C
(hLMNA; labeled with Alexa 488, green), lami-
nin-a2 (LAMA2; labeledwith Alexa 647, white),
and DAPI (blue) on engrafted tibialis anterior
(TA) muscle with 1.03 106 GFP-positive cells.
(C) Quantification of total DYSTROPHIN-pos-
itive (DYS+) regenerative myofibers on the
section transplanted with equal numbers of
GFP+ cells induced for 7 days as embryonic
mesodermal cells (day 7), GFP-positive or
-negative cells accelerated with four tran-
scription factors (+3F+DOX cells), and culture
for 4 days after sorting for GFP-positive cells
induced by four transcription factors
(cultured GFP+) or by DOX treatment alone
(+DOX). n = 3 independent replicates; p
values are determined by Dunnett’s multiple-
comparisons test. *p < 0.01.
(D) Immunostaining for PAX7 (DYS; labeled
with Alexa 594, red), human nuclear lamin
A/C (hLMNA; labeled with Alexa 488, green),
laminin-a2 (LAMA2; labeled with Alexa 647,
white), and DAPI (blue) on a section of en-
grafted TA with +3F+DOX-induced PAX3-pos-
itive cells.
(E) The quantification of total PAX7;hLMNA double-positive cell numbers on a section of transplanted myofibers to contribute as MuSCs
in vivo with cells as in (C). n = 3 independent replicates; p values are determined by Dunnett’s multiple-comparisons test. *p < 0.01.
(F) Immunodetection with MYOD antibody (labeled with Alexa 594, red) on GFP-transplanted sections. MYOD-positive cells derived from
mouse host (white arrowheads) and transplanted cells (green arrowheads) in the position of muscle satellite cells (left panel) and muscle
interstitium (right panel).
(G) Ki67 staining on a section of engrafted TA with +3F+DOX-induced GFP cells. White arrowheads indicate Ki67-positive cells (labeled with
Alexa 647). Red arrowheads have no Ki67 signals on regenerating myofibers labeled with DYSTROPHIN (DYS; labeled with Alexa 594, red)
and human nuclear lamin A/C (hLMNA; labeled with Alexa 488, green).
Error bars indicate ±SEM. Scale bars, 50 mm.
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lines, together with a different gene integration system to
control MYOD levels, will be checked in further
investigations.
In our investigation to identify regulatory factors com-
mon to MuSCs during development and in the adult, we
identified four factors that promote the formation of this
cell type from mouse and also human fibroblasts, and
from hiPSCs. Moreover we show that this induction
method leads tomorematureMuSCs compared with previ-
ously reportedmethods to induce PAX3-positivemyogenic
precursor cells from hiPSCs with several growth and chem-
ical factors (Chal et al., 2015) or induced PAX7 expression
in human embryonic stem cells/hiPSCs after the formation
of embryoid bodies (Darabi et al., 2012). This is illustrated
by high levels of transcripts of CALCR or NAP1L5, which
mark adult MuSCs under the conditions we describe with
HEY, KLF4, PAX3, and transient MYOD and which we
have not detected with the other reported induction
methods.
MYOD, although unable to promote the formation of
Pax3-GFP-positive MuSCs when overexpressed on its
own, had a positive effect in combination with other fac-
tors. This is perhaps surprising but might reflect its role as
a chromatin remodeler (de la Serna et al., 2005), facilitating
the function of the other factors that more specifically
render upstream myogenic factors accessible for transcrip-
tion. Pax3 and Pax7 genes continue to be expressed inmyo-
blasts and are only downregulated on muscle cell differen-
tiation (Young and Wagers, 2010).
One of the four transcription factors, HEYL, is involved
in Notch signaling. This signaling directly targets Hes1,
Hey1, or HeyL, known to be highly expressed in quiescent
MuSCs and essential for the generation of adult MuSCs,
to suppress MyoD transcription and to regulate myogenic
differentiation (Fukada et al., 2011). It has been reported
that interstitial PAX7-positive myogenic stem cells have
the ability to traverse the basal lamina and locate in the
interstitial region, and that this process is dependent on
Notch signaling (Bro¨hl et al., 2012). Therefore, trans-
planted cells affected by Notch signaling may be detected
as activated myogenic cells in the interstitium, although
the reason why and how Pax7+ MuSCs come to be located
outside the basal lamina are poorly understood. Another of
the factors, KLF4, a member of the family of Kruppel-like
factors, is known as a reprogramming factor that can
induce PSCs (Takahashi and Yamanaka, 2006). This factor
was chosen for the MuSC transcriptome screening because
the KLF family is essential for the maintenance of MuSCs
(Hayashi et al., 2016).
Exogenous PAX3 and/or PAX7 expression in PSCs has
been proposed to enable efficient propagation ofmyogenic
progenitors and has been used to produce myogenic stem
cells for engraftment (Darabi et al., 2012; Kim et al.,
2017). We have found that the three factors HEYL, KLF4,
and MYOD, without exogenous PAX3 also induced PAX3-
GFP cells from mesodermal cells; however, PAX7, CALCR,
or NAP1L5 transcripts in GFP+ cells without exogenous
PAX3 were all decreased and showed less myogenic differ-
entiation in vitro. Furthermore, additional expression of
PAX3/PAX7 is probably important for the long-termmain-
tenance of MuSCs (Buckingham and Relaix, 2015), and the
activation of transient PAX3 promotes ex vivo expansion of
mouse PAX7-positive MuSCs (Filareto et al., 2015). Manip-
ulation of culture medium by itself, without the introduc-
tion of expression vectors, is being used to promote the for-
mation ofmyogenic cells for cell therapy (Chal et al., 2015),
although the addition of the four factors that we describe
increased the production of MuSCs and also conferred
more adult MuSC-like properties as discussed. However,
in culture these PAX3-GFP cells did not all differentiate,
probably because of high levels of PAX3 in some cells
that prevent the normal downregulation of the protein
required for the efficient onset ofmyogenic differentiation.
Furthermore, the PAX3-GFP-expressing cells are not prob-
ably forming mature muscle on in vitro differentiation, as
indicated by the MyHC isoforms expressed, some of which
require innervation. Pax3 expression marks all myogenic
progenitors in the early embryo, and continues to be tran-
scribed in a subset of adultMuSCs (Relaix et al., 2005, 2006)
but not in the hind limbs, including the TAmuscles. In our
experiments, GFP signals were not detected in mouse TA
muscles after transplantation with induced PAX3-express-
ing cells, suggesting that Pax3 expression continues to be
downregulated in mouse limbs (Boutet et al., 2012) and
thuswill not interfere with in vivomyogenic differentiation
of transplanted cells.
Obtaining mature muscle fibers in culture presents
another challenge. The important point for any therapeu-
tic application tomuscular disorders is that candidate mus-
cle stem cells should be capable of behaving like intact
adult MuSCs in an adult skeletal muscle environment, as
we show using the induced cells derived from fibroblasts
and hiPSCs described here. Further investigation would
be required to understand the cellular andmolecularmech-
anisms of these transcription factors to induce MuSCs, and




All animal experiments were approved by the Ethics
Committee of Animal Experimentation of Kyoto Prefectural Uni-
versity of Medicine (permission number M26-237). All injections
with needles were performed under anesthesia, and all efforts
were made to minimize suffering. Pax3GFP/+, MyoD-CreIZ, and
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Rosa26CAG-LSL-tdTomato/+ mice were used for obtaining skeletal mus-
cle cells, and female Dmd /y crossed with male NSG mice (Sato
et al., 2014, Charles River) were used for the transplanted donors.
Male Dmd /y;NSG mice were used for all experiments at the indi-
cated ages.
Eight-week-old Dmd /y;NSG host male mice were used for
engraftment of freshly isolated or cultured cells derived from
hiPSCs (5.0 3 105 cells per 20 mL of PBS with 2% horse serum
[Sigma]), and 10 mM Y-27632 (Nacalai Tesque) into TA muscle fi-
bers. Mice were anesthetized with diethyl ether prior to engraft-
ment. TAmuscle was removed 4weeks after transplantation, fixed,
and stained as described below. Three independent mice for the
transplantation and ten sections of each transplanted mouse
were analyzed.
cDNA Constructs
For overexpression in mouse fibroblasts, pMXs-Gateway
vector (Addgene #18656) was used. All coding sequences of
selected 38 mouse genes were amplified by RT-PCR with KOD FX
Neo DNA polymerase (Toyobo) and single strand cDNA synthe-
sized by SuperScript 3 Reverse Transcriptase (Invitrogen) from
mouse Pax3-GFP adult MuSCs. These cDNAs were subsequently
subcloned into the pENTR1 and pMXs vectors. For human iPSCs,
piggyBac-Gateway vector was used (Addgene #20960). All human
cDNA constructs involving coding sequences were obtained from
the humanproteome expression resourceHuPEX library (Goshima
et al., 2008). Human cDNAs were transferred into the pLVX
vector (Clontech) to overexpress in human fibroblasts and the
pPiggyBac-Gateway vector with the LR clonase (Invitrogen) to
overexpress in human iPSCs.
Cell Sorting
For live cell sorting and culture, skeletal muscle of limbs and dia-
phragms of embryonic-day-16.5 embryos, diaphragms of 1-week-
oldmice at a juvenile stage, and 12-week-oldmice at an adult stage
were dissected into small pieces and treated with 0.2% of collage-
nase (Worthington) in DMEM (Nacalai Tesque) at 37C for
30 min to a few hours until the tissues disappeared. Dissociated
cell suspensions were centrifuged and resuspended with 1% BSA
(Sigma) in PBS stained with SYTOX Green or Red Dead Cell Stain
(Molecular Probes) to exclude dead cells. For mesodermal cell sort-
ing derived from human iPSCs, APC-conjugated anti-DLL1 anti-
body was used. Cell sorting and analyses were performed with
FACSJazz and FACSAria3 (Becton Dickinson).
Cell Culture
Isolated embryonic fibroblasts of Pax3-GFP;MyoD-tdTomato
mouse, or human primary dermal fibroblasts (Lonza) were
expanded onto coated dishes with 0.1% gelatin, and 10% FBS
(Gibco) in DMEM. Two independent human iPSC lines (#11-8
and #11-19 PAX3GFP/+;Tet-MYOD) were cultured on iMatrix
(Nippi)-coated dishes in StemFit AK02medium (Ajinomoto). Cells
were passaged as single cells. To induce PAX3-positive cells, we car-
ried out the initial procedure on single cells plated on Geltrex-
coated (Gibco) 6-well plates (53 104 cells/well) in mTeSR medium
(STEMCELL Technologies) supplemented with 10 mM Y-27632
for 3 days. At day 3, culture medium was changed to mesodermal
differentiation medium (50% Iscove’s modified Dulbecco’s me-
dium and 50% F12 supplemented with 1% BSA, 1% CD lipid
concentrate [Gibco], 1% insulin-transferrin-selenium [GIBCO],
20 mM 1-thioglycerol, 10 mM SB431542 [StemGent], 10 mM
CHIR99021 [StemGent], 2 mMDMH1 (Tocris), and 20 ng/mL basic
fibroblast growth factor [FGF;Wako]) for 4 days. At day 7, cells were
dissociated with TrypLE select (Gibco) and mesodermal PAX3-GFP
positives were selected by the cell sorter as DLL1-positive cells,
electroporated by NEPA21 (Nepagene), mixed with 1.0 3 106 cells
and 5 mg of plasmid DNAs, as described in Tanaka et al. (2013),
and seeded onto Geltrex-coated dishes in DMEM/F12 medium
supplemented with 20% FBS and 10 ng/mL basic FGF (MuSC me-
dium) for 24 h. At day 8, culture medium was changed to MuSC
medium supplemented with 1 ng/mL doxycycline (DOX; Tocris)
for 3 days. After DOX treatment, culture medium was changed to
MuSC medium for 2 weeks. The observation of cultured cells was
performed by BZ-X710 microscopy (Keyence).
Microarray Analyses
The datasets for gene expression in mouse Pax3-GFP-expressing
cells (embryonic day 16.5, 1 week old, 12 weeks old) and other
stem cells were obtained from the NCBI GEO database (GEO:
GSE11274 and GSE15155 [Ko et al., 2009; Pallafacchina et al.,
2010]). All of the obtained Affymetrix CEL files were imported
into GeneSpring GX (Agilent Technologies) for the calculation of
expression levels and principal component analysis. Expression
values were calculated with the GC-RMA summarization algo-
rithm as implemented in GeneSpring GX software.
qRT-PCR Analyses
Total RNAs from sorted or cultured cells were extracted using an
RNeasyMicro Kit (Qiagen). For qPCR analyses, synthesized cDNAs
were prepared using SuperScript VILO MasterMix (Invitrogen). All
qRT-PCR reactionswere carried out in triplicate using Thunder Bird
SYBR qPCR Mix (Toyobo) and Thermal Cycler Dice Realtime Sys-
tem (Takara), and normalized to mRNA expression level of mouse
or human ribosomal protein L13A as a control. Primer sequences
(50 to 30) are listed in Table S3.
Immunofluorescence
Cells and skeletal muscle tissues were fixed with 4% paraformalde-
hyde in PBS for 15 min at 4C, prior to embedding in Frozen Sec-
tion Compound (Leica Microsystems) for cryosections. Fixed sam-
ples were incubated with 0.1%Triton X-100 in PBS for 5 min,
BlockingOne (Nakacai Tesque) for 30 min, and anti-GFP (Molecu-
lar Probes A6455; diluted 1:500), anti-PAX3 (DSHB AB528426;
diluted 1:100), anti-PAX7 (DSHB AB528428; diluted 1:100), anti-
myogenin (DAKO M3559; diluted 1:100), anti-MyoD (Abcam
ab64159; diluted 1:500), anti-laminin (Enzo Life Sciences ALX-
804-190; diluted 1:500), anti-dystrophin (Abcam ab15277; diluted
1:200), anti-MyHC (R&D MAB4470; MF20, diluted 1:200), anti-
FSP1 (Abcam ab124805; diluted 1:200), anti-lamin A/C (Abcam
ab8984; diluted 1:200), and anti-Ki67 (Abcam ab15580; diluted
1:500) antibodies in 5% BlockingOne overnight at 4C. After three
washes with 0.1% Tween 20 in PBS, cells were incubated with
Alexa-conjugated anti-mouse immunoglobulin G1 (IgG1), mouse
IgG2b, rabbit IgG, or rat IgG antibodies (Molecular Probes; diluted
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1:500). Cells werewashed andmounted in ProLongDiamond anti-
fade reagent with DAPI (Molecular Probes). Images were collected
and processed by BZ-X710 microscopy.
Statistics
We report the statistical data including results of at least three bio-
logical replicates. Statistical analyses were performed with StatPlus
software (AnalystSoft) to determine significant differences from a
two-tailed distribution using a paired or unpaired Student’s t test.
The statistical significance for the comparison of multiple sample
sets was determined with Dunnett’s multiple comparisons
following ANOVA. p values are indicated on each figure as <0.05
(*) and <0.01 (**). All error bars represent mean ± SD.
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Supplemental Information can be found online at https://doi.org/
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